We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Declines More Than Market: Some Information for Investors
Read MoreHide Full Article
The latest trading session saw Medical Properties (MPW - Free Report) ending at $5.94, denoting a -0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.22%. Elsewhere, the Dow saw a downswing of 0.03%, while the tech-heavy Nasdaq depreciated by 0.33%.
The health care real estate investment trust's stock has climbed by 19.12% in the past month, exceeding the Finance sector's loss of 3.33% and the S&P 500's loss of 7.48%.
Investors will be eagerly watching for the performance of Medical Properties in its upcoming earnings disclosure. The company's upcoming EPS is projected at $0.15, signifying a 37.5% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $233.41 million, down 13.97% from the prior-year quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $0.62 per share and a revenue of $960.94 million, indicating changes of -22.5% and -3.48%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.03% downward. As of now, Medical Properties holds a Zacks Rank of #3 (Hold).
In terms of valuation, Medical Properties is presently being traded at a Forward P/E ratio of 9.66. This represents a discount compared to its industry's average Forward P/E of 11.15.
The REIT and Equity Trust - Other industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 139, placing it within the bottom 45% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Declines More Than Market: Some Information for Investors
The latest trading session saw Medical Properties (MPW - Free Report) ending at $5.94, denoting a -0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.22%. Elsewhere, the Dow saw a downswing of 0.03%, while the tech-heavy Nasdaq depreciated by 0.33%.
The health care real estate investment trust's stock has climbed by 19.12% in the past month, exceeding the Finance sector's loss of 3.33% and the S&P 500's loss of 7.48%.
Investors will be eagerly watching for the performance of Medical Properties in its upcoming earnings disclosure. The company's upcoming EPS is projected at $0.15, signifying a 37.5% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $233.41 million, down 13.97% from the prior-year quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $0.62 per share and a revenue of $960.94 million, indicating changes of -22.5% and -3.48%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.03% downward. As of now, Medical Properties holds a Zacks Rank of #3 (Hold).
In terms of valuation, Medical Properties is presently being traded at a Forward P/E ratio of 9.66. This represents a discount compared to its industry's average Forward P/E of 11.15.
The REIT and Equity Trust - Other industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 139, placing it within the bottom 45% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.